Pharmacokinetics and effects of ribavirin following intraventricular administration for treatment of subacute sclerosing panencephalitis

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 12, 2004, Pages 4631-4635

  Hosoya, Mitsuaki ^a   Mori, Shuichi ^a   Tomoda, Akemi ^b   Mori, Kenji ^c   Sawaishi, Yukio ^d   Kimura, Hiroshi ^e   Shigeta, Shiro ^a   Suzuki, Hitoshi ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

^d AKITA UNIVERSITY   (Japan)

^e NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

METHISOPRINOL; RECOMBINANT ALPHA INTERFERON; RIBAVIRIN;

ADOLESCENT; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL ARTICLE; CONJUNCTIVAL HYPEREMIA; CONTROLLED STUDY; DROWSINESS; DRUG CEREBROSPINAL FLUID LEVEL; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; FEMALE; GINGIVITIS; HEADACHE; HEMAGGLUTINATION INHIBITION; HUMAN; MALE; PRIORITY JOURNAL; SIDE EFFECT; SINGLE DRUG DOSE; SUBACUTE SCLEROSING PANENCEPHALITIS; VIRUS REPLICATION;

ADOLESCENT; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; CHILD; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISABILITY EVALUATION; ELECTROENCEPHALOGRAPHY; FEMALE; HALF-LIFE; HUMANS; INJECTIONS, INTRAVENTRICULAR; INTERFERON-ALPHA; MALE; MEASLES VIRUS; NEUROPSYCHOLOGICAL TESTS; RIBAVIRIN; SUBACUTE SCLEROSING PANENCEPHALITIS;

EID: 9644307953     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.12.4631-4635.2004     Document Type: Article

References (12)

1. Bradbury, M. W. B. 1993. Anatomy and physiology of cerebrospinal fluid, p. 19-47. In P. H. Schurr, and C. E. Polkey (ed.), Hydrocephalus. Oxford University Press, Oxford, United Kingdom.
2. Crotty, S., D. Maag, J. J. Arnold, W. Zhong, J. Y. Lau, Z. Hong, R. Andino, and C. E. Cameron. 2000. The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen. Nat. Med. 6:1375-1379.
3. Cutler, R. W., P. L. Page, J. Galicich, and G. V. Watters. 1968. Formation and absorption of cerebrospinal fluid in man. Brain 91:707-720.
4. Dyken, P. R., A. Swift, and R. H. DuRant. 1982. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with inosiplex. Ann. Neurol. 11:359-364.
5. Honda, Y., M. Hosoya, T. Ishii, S. Shigeta, and H. Suzuki. 1994. Effect of ribavirin on subacute sclerosing panencephalitis virus infections in hamsters. Antimicrob. Agents Chemother. 38:653-655.
6. Hosoya, M., S. Shigeta, K. Nakamura, and E. De Clercq. 1989. Inhibitory effects of selected antiviral compounds on measles (SSPE) virus replication in vitro. Antivir. Res. 12:87-98.
7. Hosoya, M., S. Shigeta, S. Mori, A. Tomoda, S. Shiraishi, T. Miike, and H. Suzuki. 2001. High-dose intravenous ribavirin therapy for subacute sclerosing panencephalitis. Antimicrob. Agents Chemother. 45:943-945.
8. Huffman, J. H., R. W. Sidwell, G. P. Khare, J. T. Witkowski, L. B. Allen, and R. K. Robins. 1973. In vitro effects of 1-β-D-ribofuranosil-1,2,4- triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses. Antimicrob. Agents Chemother. 3:235-241.
9. Ishii, T., M. Hosoya, S. Mori, S. Shigeta, and H. Suzuki. 1996. Effective ribavirin concentration in hamster brain for antiviral chemotherapy for subacute sclerosing panencephalitis. Antimicrob. Agents Chemother. 40:241-243.
10. Sidwell, R. W., J. H. Huffman, G. P. Khare, L. B. Allen, J. T. Witkowski, and R. K. Robins. 1972. Broad-spectrum antiviral activity of Virazole: 1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide. Science 177:705-706.
11. Tomoda, A., S. Shiraishi, M. Hosoya, A. Hamada, and T. Miike. 2001. Combined treatment with interferon-alpha and ribavirin for subacute sclerosing panencephalitis. Pediatr. Neurol. 24:54-59.
12. Tomoda, A., K Nomura, S. Shiraishi, et al. 2003. Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan. Brain Dev. 27:507-513.